Maxim Group LLC

Please email: rep@maximgrp.com To receive:  Maxim Group - Morning Minutes / Maxim Group - Equity Research First Savings Bank, Indiana Financial Group, Inc. (FSFG) covered by Michael Diana Iterum Therapeutics plc (ITRM) covered by Jason McCarthy, Ph.D. & Michael Okunewitch Ryde Group Ltd. (RYDE) covered by Allen Klee Please visit https://lnkd.in/egxnBQwJ for important disclosures.

Please email: rep@maximgrp.com To receive:  Maxim Group - Morning Minutes / Maxim Group - Equity Research Seanergy Maritime Holdings Corp. (SHIP) covered by Tate Sullivan, CFA MANHATTAN BRIDGE CAPITAL, Inc. (LOAN) covered by Michael Diana BM Technologies, Inc. (BMTX) f/k/a BankMobile covered by Michael Diana Globus Maritime Limited (GLBS) covered by Tate Sullivan, CFA Please visit https://lnkd.in/egxnBQwJ for important disclosures.

TuanChe (NASDAQ: TC) Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement. Maxim Group LLC is acting as the exclusive Placement Agent. Read the full press release: https://lnkd.in/enBmfMTD Alex Jin, Kyle Gao, Matthew Mavrogian, Yingran Zhu

Please email: rep@maximgrp.com To receive:  Maxim Group - Morning Minutes / Maxim Group - Equity Research reAlpha Tech Corp. (AIRE) covered by Allen Klee Annovis Bio, Inc. (ANVS) covered by Jason McCarthy, Ph.D. & Michael Okunewitch Hall of Fame Resort & Entertainment Company (HOFV) covered by Michael Diana & Jack Vander Aarde Beyond, Inc.(BYON) covered by Tom Forte, CFA LendingClub Corporation (LC) covered by Tom Forte, CFA Barfresh Food Group Inc (BRFH) covered by Anthony Vendetti Dogwood Therapeutics, Inc. (DWTX) covered by Jason McCarthy, Ph.D. & Michael Okunewitch Please visit https://lnkd.in/egxnBQwJ for important disclosures.

WISeKey SA(SIX: WIHN, NASDAQ: WKEY) secures $30 million through convertible notes. Maxim Group LLC acted as the sole placement agent for the private placements. Read the full press release: https://lnkd.in/e3JFtxfg Chris Avery, Sam Teller

The SPACtator Report: Inaugural Edition. A comprehensive summary of SPAC market activities YTD as of October 24th, 2024 To receive the Maxim Group SPAC Report, please email: rep@maximgrp.com. Please visit https://lnkd.in/egxnBQwJ for important disclosures. A “Special Purpose Acquisition Company” (“SPAC”) is a shell or “blank-check” company that has no operations but goes public with the intention of merging with or acquiring a company with proceeds raised in the SPAC’s IPO. The SPAC Market in the U.S. includes all SPACs listed on U.S. National exchanges (NYSE, Nasdaq). This report details key statistics, trends, and other data relevant to SPACs and the transactions conducted within their segment. Some companies that Maxim Group LLC mentions in this report are Emerging Growth companies whose securities typically involve a higher degree of risk and more volatility than the securities of more established companies. The securities discussed in this report may not be suitable for some investors. Investors must make their own determination as to the appropriateness of an investment in any securities referred to herein, based on their specific investment objectives, financial status and risk tolerance. This communication is neither an offer to sell nor a solicitation of an offer to buy any securities mentioned herein. This publication is for information purposes only. Larry Glassberg, RITESH VEERA, Joseph Daneshgar, Jackson Tittle, CFA

Please email: rep@maximgrp.com To receive:  Maxim Group - Morning Minutes / Maxim Group - Equity Research Viking Therapeutics, Inc. (VKTX) covered by Naz Rahman, CFA & Jason McCarthy, Ph.D. Genelux Corporation (GNLX) covered by Jason McCarthy, Ph.D. & Michael Okunewitch Aprea Therapeutics, Inc. (APRE) covered by Jason McCarthy, Ph.D. & Michael Okunewitch Worksport Ltd (WKSP) covered by Tate Sullivan, CFA PainReform Ltd (PRFX) covered by Naz Rahman, CFA & Jason McCarthy, Ph.D. Please visit https://lnkd.in/egxnBQwJ for important disclosures.

Last week, we hosted our 2024 Maxim Inaugural Pickleball Tournament at CityPickle. Thank you to all who participated— we look forward to bringing the Maxim family together for more exciting events in the near future. 1st Place: David Burch & Joshua Winer 2nd Place: RITESH VEERA & Chris Avery 3rd Place: Danny Fossey & Mason O'Neill

During our 2024 Healthcare Virtual Summit, Maxim Senior Analysts hosted a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management. Access replays here: https://lnkd.in/gSPAicYu Aclarion, Inc. (ACON) Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) Aethlon Medical, Inc. (AEMD) AIM ImmunoTech Inc. (AIM) Alterity Therapeutics Limited (ATHE) Alzamend Neuro, Inc. (ALZN) Applied DNA Sciences, Inc. (APDN) Aprea Therapeutics, Inc. (APRE) Artelo Biosciences, Inc. (ARTL) Assertio Holdings, Inc. (ASRT) atai Life Sciences (ATAI) Atossa Therapeutics, Inc. (ATOS)  Autonomix Medical, Inc. (AMIX) Avenue Therapeutics (ATXI) Aytu BioPharma, Inc. (AYTU) Azitra Inc, Inc. (AZTR) Belite Bio, Inc. (BLTE) bioAffinity Technologies, Inc. (BIAF) Bionomics Ltd (BNOX) BioRestorative Therapies, Inc. (BRTX) Brainstorm Cell Therapeutics Inc. (BCLI) Chemomab Therapeutics Ltd. (CMMB) Citius Pharmaceuticals, Inc. (CTXR) Clene Nanomedicine, Inc. (CLNN) CNS Pharmaceuticals, Inc. (CNSP) Context Therapeutics Inc. (CNTX) Daxor Corporation (DXR) Dermata Therapeutics, Inc. (DRMA) electroCore, Inc.  (ECOR) Enlivex Therapeutics (Nasdaq: ENLV)   Femasys Inc. (FEMY) FibroBiologics (Nasdaq: FBLG) Gain Therapeutics, Inc. (GANX) Genelux Corporation (GNLX) Genenta Science S.p.A. (GNTA) Immuron Limited (IMRN) Immutep Limited (IMMP) Indaptus Therapeutics, Inc. (INDP) Inhibikase Therapeutics, Inc. (IKT) INmune Bio Inc. (INMB)

Please email: rep@maximgrp.com To receive:  Maxim Group - Morning Minutes / Maxim Group - Equity Research AIM ImmunoTech Inc. (AIM) covered by Jason McCarthy, Ph.D. & Michael Okunewitch Cheche Group Inc. (CCG) covered by Allen Klee Immutep Limited (IMMP) covered by Jason McCarthy, Ph.D. & Michael Okunewitch Rani Therapeutics Holdings, Inc. (RANI) covered by Michael Okunewitch & Jason McCarthy, Ph.D. Inhibikase Therapeutics, Inc. (IKT) covered by Jason McCarthy, Ph.D. Please visit https://lnkd.in/egxnBQwJ for important disclosures.